BD is one of the world’s largest pure-play medical technology companies with a Purpose of advancing the world of health™ by driving innovation across medical essentials, connected care, biopharma systems and interventional. The company supports those on the frontlines of healthcare by developing transformative technologies, services and solutions that optimize clinical operations and improve care for patients. Operating across the globe, with more than 60,000 employees, BD delivers billions of products annually that have a positive impact on global healthcare. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase clinical efficiency, improve safety and expand access to healthcare.
- Members
Ivy Parks President
Ivy Parks is the President of BD (Becton, Dickinson and Company) Canada. Ivy leads the Canadian organization of approximately 400 associates working towards advancing the world of health TM. In her leadership role, Ivy partners with stakeholders to positively impact healthcare delivery while continuing to transform the organization to better serve the needs of the evolving healthcare marketplace and ultimately impacting positive patient outcomes. Ivy brings extensive market experience to this position. Having been with BD in Canada since 2000 in different roles with growing responsibilities, Ivy has a deep understanding of acute care, alternate care, laboratory areas, as well as key industry stakeholders and medical technology associations. Before assuming the President role in 2021, Ivy led BD-Canada Integrated Diagnostics Solutions (IDS) business. In this role, she collaborated with federal and provincial governments and orchestrated efforts for successfully delivering millions of PCR and point-of-care tests to Canadians in response to the COVID-19 pandemic. Ivy holds an Honours Bachelor of Science degree in Biology from Western University.
